Three months ago Entegris abandoned the cautious, wait-and-see tone of the past year and told a confident upcycle story. Revenue growth was accelerating, gross margin hit its highest level since early 2022, debt was falling faster than planned, and the capital-spending business had flipped from decline to double-digit growth. The third-quarter report, due before the open on October 29, is the first chance to show that story holds up in the numbers. The catch is that analysts have already priced in a strong result.
Consensus calls for earnings of $1.04 a share on revenue of $924.5 million. That would mean roughly 44% earnings growth and 14.5% revenue growth from a year ago, a clear step up from the 11% revenue growth posted last quarter. Management guided to $0.96 to $1.04 a share on revenue of $905 million to $935 million. The Street's revenue figure sits comfortably in the upper half of that range. On earnings, however, analysts are at the very top of guidance. That leaves little room for an ordinary beat. Entegris probably needs revenue near the high end, plus gross margin at or above the 47.5% to 48.5% guided range, to clear the bar convincingly.
Gross margin is the line that matters most. It climbed from 43.6% a year ago to 47.6% last quarter, and management attributed part of that gain to structural improvements. Several self-help items should show up in this report:
the Taiwan KSP facility was expected to break even this quarter, ahead of schedule;
the exit from a dilutive life-sciences business should help the mix;
the Logan, Utah closure is another cost rationalization.
A margin print near 48% would support the claim that the gains are durable rather than cyclical. A slip back toward 47% would raise questions, especially if the Materials Solutions segment's margin stays stuck near 21% while the company keeps investing in direct labor.
On demand, the key evidence is whether capex-related revenue keeps building. Management said it was tracking more than 20 leading-edge fab expansions across advanced logic, memory and packaging, with industry equipment orders up 20% to 30%. It was careful to say most of the fab-construction benefit lands in 2027. Investors should look for continued growth in bookings and backlog, along with commentary that the project list is holding or growing. Also important are signs that newer catalysts are turning into revenue: HBM4 and through-silicon via CMP wins, molybdenum demand that roughly doubled last quarter, and a liquid filtration business coming off four straight record quarters. Mainstream logic remains the soft spot, and a possible memory shortage that pressures consumer end markets is a risk worth watching.
The fourth-quarter outlook may matter more than the quarter itself. Management signaled mid-teens year-over-year growth but only about 4% sequential growth, which some analysts saw as conservative. Firming or raising that view would extend a pattern of rising guidance on margins, market growth and leverage. With the Investor Day on November 9, though, management may hold back longer-term targets until then. Deleveraging is a secondary check: net leverage stood at 3.4x, and the year-end goal is now the high 2s.
Sentiment has improved but is still negative. The reading moved from moderately bearish before last quarter to a milder bearish stance now. The stock has gained 4.3% since the last report, beating the S&P 500 by about three points. At $142.90 it sits above its 200-day moving average but well below the post-earnings high near $170, inside a range narrower than the previous quarter's large swings. That is not a stretched setup. Even so, earnings expectations sit at the top of guidance. The question is whether Entegris can show that margin gains and capex momentum are compounding fast enough to push estimates higher, rather than just meeting the targets it set itself.